Product Information

OLOPATADINE HCL 0.1% EYE DROP is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.1715 per ML under NDC 16571088205. Its NADAC has been published 65 times since Aug 27, 2025.

FDA first approved this application on Mar 21, 2018.

OLOPATADINE HCL 0.1% EYE DROP

olopatadine hydrochloride
$1.1715per ML
OTC

Strength

1 mg/mL

NDC

16571088205

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204392

FDA Approved

3/21/2018

On Market Since

5/1/2025

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE HCL 0.1% EYE DROP has been published 65 times since Aug 27, 2025, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1715 per ML
All-time high$1.3149 (Sep 10, 2025)
All-time low$1.1715 (Nov 18, 2026)
52-week high$1.2737
52-week low$1.1715
Median price$1.2394
Average price$1.2416
Largest weekly change-5.5% (Nov 18, 2026)
Weeks tracked65
Tracking sinceAug 27, 2025

Price History

1W

-5.5%

1M

-5.5%

3M

-7.6%

6M

-4.0%

1Y

-6.5%

3Y

N/A

5Y

N/A

All

-10.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olopatadine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.1% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.1% EYE DROP, manufactured by Rising Pharma Holdings Inc., is $1.1715 per ML (NDC 16571088205), effective Nov 18, 2026.

How has the price of OLOPATADINE HCL 0.1% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has declined 10.9%. It has been tracked across 65 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.1% EYE DROP?

Since Aug 27, 2025, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has ranged from a low of $1.1715 (Nov 18, 2026) to a high of $1.3149 (Sep 10, 2025), with a median of $1.2394 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.1% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.1% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OLOPATADINE HCL 0.1% EYE DROP?

OLOPATADINE HCL 0.1% EYE DROP (NDC 16571088205) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.